<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000zi 4500</marc:leader>
    <marc:controlfield tag="001">9.926970</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20231116124145</marc:controlfield>
    <marc:controlfield tag="006">m     o  d f      </marc:controlfield>
    <marc:controlfield tag="007">cr mn|||||||||</marc:controlfield>
    <marc:controlfield tag="008">230906s2023    onca    ob   f000 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
      <marc:subfield code="e">rda</marc:subfield>
      <marc:subfield code="c">CaOODSP</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="045" ind1=" " ind2=" ">
      <marc:subfield code="a">x9y2</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">HP5-164/2023E-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="0" ind2="0">
      <marc:subfield code="a">Evaluation of the Public Health Agency of Canada's tuberculosis activities 2015-16 to 2020-21 / </marc:subfield>
      <marc:subfield code="c">prepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="246" ind1="1" ind2="7">
      <marc:subfield code="a">Evaluation of the PHAC's tuberculosis activities</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="264" ind1=" " ind2="1">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, </marc:subfield>
      <marc:subfield code="c">2023.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">1 online resource (ix, 29 pages) : </marc:subfield>
      <marc:subfield code="b">colour illustrations</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="336" ind1=" " ind2=" ">
      <marc:subfield code="a">text</marc:subfield>
      <marc:subfield code="b">txt</marc:subfield>
      <marc:subfield code="2">rdacontent</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="337" ind1=" " ind2=" ">
      <marc:subfield code="a">computer</marc:subfield>
      <marc:subfield code="b">c</marc:subfield>
      <marc:subfield code="2">rdamedia</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="338" ind1=" " ind2=" ">
      <marc:subfield code="a">online resource</marc:subfield>
      <marc:subfield code="b">cr</marc:subfield>
      <marc:subfield code="2">rdacarrier</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Issued also in French under title: Évaluation des activités de l'Agence de la santé publique du Canada liées à la tuberculose de 2015-2016 à 2020-2021.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Cover title.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"February 2023."</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="504" ind1=" " ind2=" ">
      <marc:subfield code="a">Includes bibliographical references (pages 26-29).</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"This report presents findings from the evaluation of the Public Health Agency of Canada's (PHAC) tuberculosis (TB) activities from April 2015 to March 2021. The evaluation focused on the extent to which PHAC's current approach is appropriate to address the needs of each at-risk population, how scientific and performance information, as well as stakeholders' perspectives, are guiding TB activities and the contribution of PHAC activities to reducing TB rates in Canada. PHAC's TB activities were previously evaluated in 2015. To address these questions, data was collected from a review of literature, internal documents, financial, performance, and scientific data, as well as a comparison of TB strategies and practices with other low-incidence countries, and a case study on the difference in US-Canada incidence rates. Data was analyzed by triangulating information gathered from the different lines of evidence listed above, to increase the reliability and credibility of evaluation findings and conclusions"--Evaluation scope and methodology, page 1.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="610" ind1="2" ind2="0">
      <marc:subfield code="a">Public Health Agency of Canada</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Tuberculosis</marc:subfield>
      <marc:subfield code="x">Government policy</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Tuberculosis</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="x">Prevention</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Public health surveillance</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="x">Evaluation.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Health Canada. </marc:subfield>
      <marc:subfield code="b">Office of Audit and Evaluation, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="2" ind2=" ">
      <marc:subfield code="a">Public Health Agency of Canada. </marc:subfield>
      <marc:subfield code="b">Office of Audit and Evaluation, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Évaluation des activités de l'Agence de la santé publique du Canada liées à la tuberculose de 2015-2016 à 2020-2021 / </marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.930398</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">1.17 MB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2023/sc-hc/HP5-164-2023-eng.pdf</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2=" ">
      <marc:subfield code="q">HTML</marc:subfield>
      <marc:subfield code="s">N/A</marc:subfield>
      <marc:subfield code="u">https://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/phac-tuberculosis-activities-2015-2021.html</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
